Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.

Hatter L, Holliday M, Oldfield K, Kearns C, Barry T, Black M, Bruce P, Colman A, Dickinson E, Eathorne A, Harwood M, Hills T, Lamb R, Kerse K, Krishnamoorthy S, Martindale J, Semprini A, Shortt N, McNamara D, Byrnes CA, Dalziel SR, Bush A, Weatherall M, Beasley R, CARE study team

Open source

DOI
10.1016/s0140-6736(25)00861-x
Published
2025 Oct 4
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-00861-x,
  title = {Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.},
  author = {Hatter L and Holliday M and Oldfield K and Kearns C and Barry T and Black M and Bruce P and Colman A and Dickinson E and Eathorne A and Harwood M and Hills T and Lamb R and Kerse K and Krishnamoorthy S and Martindale J and Semprini A and Shortt N and McNamara D and Byrnes CA and Dalziel SR and Bush A and Weatherall M and Beasley R and CARE study team},
  year = {2025},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(25)00861-x},
  url = {https://doi.org/10.1016/s0140-6736(25)00861-x}
}

RIS

TY  - JOUR
TI  - Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
AU  - Hatter L
AU  - Holliday M
AU  - Oldfield K
AU  - Kearns C
AU  - Barry T
AU  - Black M
AU  - Bruce P
AU  - Colman A
AU  - Dickinson E
AU  - Eathorne A
AU  - Harwood M
AU  - Hills T
AU  - Lamb R
AU  - Kerse K
AU  - Krishnamoorthy S
AU  - Martindale J
AU  - Semprini A
AU  - Shortt N
AU  - McNamara D
AU  - Byrnes CA
AU  - Dalziel SR
AU  - Bush A
AU  - Weatherall M
AU  - Beasley R
AU  - CARE study team
PY  - 2025
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(25)00861-x
UR  - https://doi.org/10.1016/s0140-6736(25)00861-x
ER  - 

APA

L, H., M, H., K, O., C, K., T, B., M, B., P, B., A, C., E, D., A, E., M, H., T, H., R, L., K, K., S, K., J, M., A, S., N, S., D, M., CA, B., SR, D., A, B., M, W., R, B., & team, C. S. (2025). Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)00861-x

Source records